Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
1 ФГБОУ ВО «Кемеровский государственный медицинский университет» Минздрава России, Кемерово, Россия; 2 Государственная образовательная организация ВПО «Донецкий национальный медицинский университет им. М. Горького», Донецк, Россия; 3 ГАУЗ «Кузбасская клиническая больница скорой медицинской помощи им. М.А. Подгорбунского», Кемерово, Россия
Список исп. литературыСкрыть список 1. World Health Organization, International Agency for Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans: schistosomes, liver lukes, and Helicobacter pylori. Vol 61 Lyon: IARC, 1994. First published: 3 March 1995. DOI: 10.1002/ ijc.2910600502 2. Liu H, Chen YT, Wang R et al. Helicobacter pylori infection, atrophic gastritis, and pancreatic cancer risk: a meta-analysis of prospective epidemiologic studies. Medicine 2017; 96: e7811. DOI: 10.1097/MD. 0000000000007811 3. Yoshida T, Kato J, Inoue I et al. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer. Int J Cancer 2014; 134: 1445–57. DOI: 10.1002/ijc.28470 4. Chen XZ, Schöttker B, Castro FA et al. Association of helicobacter pylori infection and chronic atrophic gastritis with risk of colonic, pancreatic and gastric cancer: a ten-year follow-up of the ESTHER cohort study. Oncotarget 2016; 7: 17182–93. DOI: 10.18632/oncotarget.7946 5. Song H, Held M, Sandin S et al. Increase in the prevalence of atrophic gastritis among adults age 35 to 44 years old in Northern Sweden between 1990 and 2009. Clin Gastroenterol Hepatol 2015; 13: 1592–600. e1591. DOI: 10.1016/j.cgh.2015.04.001 6. Kayali S, Manfredi M, Gaiani F et al. Helicobacter pylori, transmission routes and recurrence of infection: state of the art. Acta Bio-Medica: Atenei Parmensis 2018; 89 (8-s): 72–6. DOI: 10.23750/abm. v89i8-S.7947 7. Mladenova I, Durazzo M. Transmission of Helicobacter pylori. Minerva gastroenterologica e dietologica 2018; 64 (3): 251–54. DOI: 10.23736/s1121-421x.18.02480-7 8. Hooi JKY, Lai WY, Ng WK et al. Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis. Gastroenterology 2017; 153 (2): 420–29. DOI: 10.1053/j.gastro.2017.04.022 9. Rokkas T, Pistiolas D, Sechopoulos P et al. Relationship between Helicobacter pylori infection and esophageal neoplasia: a meta-analysis. Clin Gastroenterol Hepatol 2007; 5 (12): 1413–7, 17.e1-2. DOI: 10.1016/j.cgh.2007.08.01 10. Mungan Z, Pınarbası Şimşek B. Gastroesophageal reflux disease and the relationship with Helicobacter pylori. Turkish J Gastroenterol 2017; 28 (Suppl. 1): S61–s67. DOI: 10.5152/tjg.2017.16 11. de Martel C, Georges D, Bray F et al. Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Global Health 2020; 8 (2): e180–e90. DOI: 10.1016/s2214-109x(19)30488-7 12. Zuo Y, Jing Z, Bie M et al. Association between Helicobacter pylori infection and the risk of colorectal cancer: A systematic review and meta-analysis. Medicine (Baltimore) 2020; 99 (37): e21832. DOI: 10.1097/md.0000000000021832 13. Poorolajal J, Moradi L, Mohammadi Y et al. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidemiol Health 2020; 42: e2020004. DOI: 10.4178/epih.e2020004 14. Ford AC, Gurusamy KS, Delaney B et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev 2016; 4 (4): Cd003840. DOI: 10.1002/14651858. CD003840.pub5 15. Mansori K, Moradi Y, Naderpour S et al. Helicobacter pylori infection as a risk factor for diabetes: a meta-analysis of case-control studies. BMC Gastroenterology 2020; 20 (1): 77. DOI: 10.1186/s12876-020-01223-0 16. Fang Y, Fan C, Xie H. Effect of Helicobacter pylori infection on the risk of acute coronary syndrome: A systematic review and meta-analysis. Medicine (Baltimore) 2019; 98 (50): e18348. DOI: 10.1097/md.0000000000018348 17. Wei X, Zhao HQ, Ma C et al. The association between chronic periodontitis and oral Helicobacter pylori: A meta-analysis. PLoS One 2019; 14 (12): e0225247. DOI: 10.1371/journal.pone.0225247 18. Liu R, Liu Q, He Y et al. Association between Helicobacter pylori infection and nonalcoholic fatty liver: A meta-analysis. Medicine (Baltimore) 2019; 98 (44): e17781. DOI: 10.1097/md.0000000000017781 19. Chen Q, Zhou X, Tan W et al. Association between Helicobacter pylori infection and Sjögren syndrome: A meta-analysis. Medicine (Baltimore) 2018; 97 (49): e13528. DOI: 10.1097/md.0000000000013528 20. Li X, Peng L, Shen X et al. The Association between Infertility and Helicobacter pylori Infection: a Meta-Analysis of Case-control Studies. Clinical Laboratory 2018; 64 (9): 1385–93. DOI: 10.7754/Clin.Lab. 2018.180206 21. Yong WC, Upala S, Sanguankeo A. Helicobacter pylori infection in systemic sclerosis: a systematic review and meta-analysis of observational studies. Clin Exp Rheumatol 2018; 36 Suppl. 113 (4): 168–74. 22. Bellos I, Daskalakis G, Pergialiotis V. Helicobacter pylori infection increases the risk of developing preeclampsia: A meta-analysis of observational studies. Int J Clin Pract 2018; 72 (2). DOI: 10.1111/ijcp.13064 23. Poorolajal J, Moradi L, Mohammadi Y et al. Risk factors for stomach cancer: a systematic review and meta-analysis. Epidem Health 2020; 42: e2020004. DOI: 10.4178/epih.e2020004 24. Исаков В.А., Домарадский И.В. Хеликобактериоз. М.: Медпрактика-М, 2003. [Isakov V.A., Domaradskij I.V. Helikobakterioz. Moscow: Medpraktika-M, 2003 (in Russian).] 25. Голиков П.П. Оксид азота в клинике неотложных заболеваний. М.: Медпрактика-М, 2004. [Golikov P.P. Oksid azota v klinike neotlozhnyh zabolevanij. Moscow: Medpraktika-M, 2004 (in Russian).] 26. Gobert AP, McGee DJ, Akhtar M et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: a strategy for bacterial survival. Proc Natl Acad Sci USA 2001; 98 (24): 13844–9. DOI: 10.1073/pnas.241443798 27. von Bothmer C, Edebo A, Lonroth H et al. Helicobacter pylori infection inhibits antral mucosal nitric oxide production in humans. Scand J Gastroenterol 2002; 37 (4): 404–8. DOI: 10.1080/003655202317316024 28. Chautrand T, Souak D, Chevalier S, Duclairoir-Poc C. Gram-Negative Bacterial Envelope Homeostasis under Oxidative and Nitrosative Stress. Microorganisms 2022; 10 (5): 924. DOI: 10.3390/microorganisms10050924 29. Park AM, Nagata K, Sato EF et al. Mechanism of strong resistance of Helicobacter pylori respiration to nitric oxide. Arch Biochem Biophys 2003; 411 (1): 129–35. 30. Rieder G, Hofmann JA, Hatz RA et al. Up-regulation of inducible nitric oxide synthase in Helicobacter pylori-associated gastritis may represent an increased risk factor to develop gastric carcinoma of the intestinal type. Int J Med Microbiol 2003; 293 (6): 403–12. DOI: 10.1078/1438-4221-00280 31. Li CQ, Pignatelli B, Ohshima H. Coexpression of interleukin-8 and inducible nitric oxide synthase in gastric mucosa infected with cagA+ Helicobacter pylori. Dig Dis Sci 2000; 45 (1): 55–62. DOI: 10.1023/a:1005453125433 32. Mintz J, Vedenko A, Rosete O et al. Current Advances of Nitric Oxide in Cancer and Anticancer Therapeutics. Vaccines (Basel) 2021; 9 (2): 94. DOI: 10.3390/vaccines9020094